Emily Ricotta, PhD, MSc

home / authors / emily-ricotta-phd-msc

Assistant Professor of Epidemiology in the Preventive Medicine and Biostatistics Department at Uniformed Services University.

Articles

Strengthening Observational Studies: Community Engagement and Data Practices

Strengthening Observational Studies: Community Engagement and Data Practices

Sophia Abene;Emily Ricotta, PhD, MSc
February 18th 2025

Emily Ricotta, PhD, MSc outlines the importance of involving affected populations and refining data collection methods to improve early decision-making during epidemics

Read More

The Role of Observational Studies in Epidemic Responses

The Role of Observational Studies in Epidemic Responses

Sophia Abene;Emily Ricotta, PhD, MSc
February 17th 2025

Emily Ricotta, PhD, MSc, discusses how observational studies shape early decisions and address challenges in infectious disease outbreaks

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
US Health Policy Changes Threaten Global Public Health Cooperation
Published: February 14th 2025 | Updated: February 21st 2025
US Health Policy Changes Threaten Global Public Health Cooperation
Science Is Science: Navigating Clinical Trust Amid Political Shifts
Published: February 14th 2025 | Updated: February 21st 2025
Science Is Science: Navigating Clinical Trust Amid Political Shifts
Study Links Genetic Variations in Cryptococcus neoformans to Disease Outcomes
Published: February 7th 2025 | Updated: February 21st 2025
Study Links Genetic Variations in Cryptococcus neoformans to Disease Outcomes
Federal Government Changes May Influence Avian Influenza Surveillance and Disease Prevention
Published: February 10th 2025 | Updated: February 21st 2025
Federal Government Changes May Influence Avian Influenza Surveillance and Disease Prevention
Five All-Oral Regimens Show Efficacy in the Phase 3 endTB Trial for Rifampin-Resistant TB
Published: February 10th 2025 | Updated: February 21st 2025
Five All-Oral Regimens Show Efficacy in the Phase 3 endTB Trial for Rifampin-Resistant TB
© 2025 MJH Life Sciences

All rights reserved.